BCL2 and acute myeloid leukemia: Taken together, these findings confirmed that combination of CDK7 and BCL2 via XL102 reduces proliferation, amplifies apoptosis and found to be highly synergistic in AML cell lines, primary myeloid blasts and AML xenografts.